Prediction of nonSVR to therapy with pegylated interferon-alpha2a and ribavirin in chronic hepatitis C genotype 1 patients after 4, 8 and 12 weeks of treatment (Q42991289)
Jump to navigation
Jump to search
scientific article published on 25 September 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prediction of nonSVR to therapy with pegylated interferon-alpha2a and ribavirin in chronic hepatitis C genotype 1 patients after 4, 8 and 12 weeks of treatment |
scientific article published on 25 September 2009 |
Statements
1 reference
Prediction of nonSVR to therapy with pegylated interferon-alpha2a and ribavirin in chronic hepatitis C genotype 1 patients after 4, 8 and 12 weeks of treatment (English)
1 reference
1 reference
1 reference
E Lukasiewicz
1 reference
M Gorfine
1 reference
L S Freedman
1 reference
S W Schalm
1 reference
S Zeuzem
1 reference
A U Neumann
1 reference
DITTO-HCV Study Group
1 reference
25 September 2009
1 reference
1 reference
Identifiers
1 reference